$0.360
-0.015 (-4.05%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
PharmaCyte Biotech Inc (PMCB) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting PMCB is Sell.
PharmaCyte Biotech Inc (PMCB) 20-Day simple moving average is 0.35, while PharmaCyte Biotech Inc (PMCB) share price is $—, making it Buy.
PharmaCyte Biotech Inc (PMCB) 60-Day simple moving average is 0.42, while PharmaCyte Biotech Inc (PMCB) share price is $—, making it Sell.
Technical Analysis for PMCB
AI Technical PMCBAs of 2026-11-07, the technical board for PharmaCyte Biotech Inc (PMCB) reads sell: 4 indicators are flashing buy, 5 are indicating sell, and 4 are neutral. Price at $0.36 sits below the 60-day and 200-day moving averages and above the 5-day, 10-day and 20-day.
Momentum readings: RSI stands at 47.819, MACD stands at -0.0152 (Sell), Stochastic %K stands at 58.845, Stochastic %D stands at 50.768 and CCI stands at 76.486.
PMCB trades below the 60-day SMA (0.42) and below the 200-day SMA (0.63). Immediate resistance sits at Classic R1 0.41, then R2 0.47. Support sits at Classic S1 0.29, then S2 0.24.
PharmaCyte Biotech Inc (PMCB) Support & Resistance Level
PharmaCyte Biotech Inc (PMCB) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 47.819 |
| STOCHk_14_3_3 | 58.845 |
| STOCHd_14_3_3 | 50.768 |
| CCI_20 | 76.486 |
| AO_5_34 | -0.032 |
| MOM_10 | 0.005 |
| MACD_12_26_9 | -0.015 |
PharmaCyte Biotech Inc (PMCB) Relative Strength Index (RSI_14) is 47.819, creating a Neutral signal.
PharmaCyte Biotech Inc (PMCB) Stochastic %K is 58.845, creating a Neutral signal.
PharmaCyte Biotech Inc (PMCB) Stochastic %D is 50.768, creating a Neutral signal.
PharmaCyte Biotech Inc (PMCB) CCI_20 is 76.486, creating a Neutral signal.
PharmaCyte Biotech Inc (PMCB) Awesome Oscillator (AO) is -0.032, creating a Sell signal.
PharmaCyte Biotech Inc (PMCB) Momentum (MOM) is 0.005, creating a Buy signal.
PharmaCyte Biotech Inc (PMCB) Moving Average Convergence Divergence (MACD) is -0.015, creating a Sell signal.
PharmaCyte Biotech Inc (PMCB) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.353 | Buy |
| MA_10 | 0.343 | Buy |
| MA_20 | 0.347 | Buy |
| MA_60 | 0.425 | Sell |
| MA_200 | 0.631 | Sell |
| MA_250 | 0.675 | Sell |
PharmaCyte Biotech Inc (PMCB) 5-Day simple moving average is 0.353, while PharmaCyte Biotech Inc (PMCB) share price is $, making it a Buy.
PharmaCyte Biotech Inc (PMCB) 10-Day simple moving average is 0.343, while PharmaCyte Biotech Inc (PMCB) share price is $, making it a Buy.
PharmaCyte Biotech Inc (PMCB) 20-Day simple moving average is 0.347, while PharmaCyte Biotech Inc (PMCB) share price is $, making it a Buy.
PharmaCyte Biotech Inc (PMCB) 60-Day simple moving average is 0.425, while PharmaCyte Biotech Inc (PMCB) share price is $, making it a Sell.
PharmaCyte Biotech Inc (PMCB) 200-Day simple moving average is 0.631, while PharmaCyte Biotech Inc (PMCB) share price is $, making it a Sell.
PharmaCyte Biotech Inc (PMCB) 250-Day simple moving average is 0.675, while PharmaCyte Biotech Inc (PMCB) share price is $, making it a Sell.
Related articles
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.